Michael F. Concino

Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and Necrosis

Harlan F. Weisman, Michelle K. Leppo, Henry C. Marsh et al. · Science · 1990 · 979 citations

Life Sciences, Immunology, Pharmacology +17

A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice.

Antonio R. Arulanandam, Philippe Moingeon, Michael F. Concino et al. · The Journal of Experimental Medicine · 1993 · 122 citations · Full text

Life Sciences, Immunology, Molecular Biology +14

Recombinant soluble human complement receptor type 1 inhibits inflammation in the reversed passive arthus reaction in rats

Chen‐Hao Yeh, Henry C. Marsh, Gerald Carson et al. · The Journal of Immunology · 1991 · 94 citations · Full text

Life Sciences, Immunology, Pathology +17

The adenovirus major late promoter TATA box and initiation site are both necessary for transcription<i>in vitro</i>

Michael F. Concino, Richard F. Lee, James P. Merryweather et al. · Nucleic Acids Research · 1984 · 94 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

The gamma and epsilon subunits of the CD3 complex inhibit pre-Golgi degradation of newly synthesized T cell antigen receptors.

Thomas Wileman, Gerald Carson, Michael F. Concino et al. · The Journal of Cell Biology · 1990 · 79 citations · Full text

Life Sciences, Cell Biology, Immunology +17